MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

Search

Assertio Holdings Inc

Atidarymo kaina

0.67 -1.47

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.67

Max

0.69

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.1M

-14M

Pardavimai

-5.7M

26M

Pelno marža

-51.121

Darbuotojai

58

EBITDA

-10M

-13M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+305.8% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.9M

63M

Ankstesnė atidarymo kaina

2.14

Ankstesnė uždarymo kaina

0.67

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Assertio Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-11 22:19; UTC

Įsigijimai, susijungimai, perėmimai

FCC Approves U.S. Cellular Sale to T-Mobile

2025-07-11 17:28; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Gains on Ethereum Purchase

2025-07-11 16:57; UTC

Uždarbis

BASF Cuts Outlook on Global Economy Uncertainty

2025-07-13 23:54; UTC

Rinkos pokalbiai

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

2025-07-13 23:49; UTC

Rinkos pokalbiai

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

2025-07-13 23:49; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-13 23:40; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-13 23:40; UTC

Rinkos pokalbiai

Gold Advances Amid Rising Trade Tensions -- Market Talk

2025-07-13 23:39; UTC

Rinkos pokalbiai

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

2025-07-13 23:13; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-13 23:13; UTC

Rinkos pokalbiai

Ryman Healthcare Could Be Turning a Corner -- Market Talk

2025-07-13 11:00; UTC

Įsigijimai, susijungimai, perėmimai

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

2025-07-12 02:24; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

2025-07-11 21:45; UTC

Rinkos pokalbiai

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

2025-07-11 19:46; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

2025-07-11 19:45; UTC

Rinkos pokalbiai

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

2025-07-11 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

2025-07-11 18:18; UTC

Rinkos pokalbiai

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

2025-07-11 17:35; UTC

Rinkos pokalbiai

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

2025-07-11 17:26; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

2025-07-11 16:53; UTC

Rinkos pokalbiai

Crude Futures Add to Early Gains -- Market Talk

2025-07-11 16:42; UTC

Uždarbis

BASF Cuts Outlook on Global Economic Uncertainty

2025-07-11 16:08; UTC

Rinkos pokalbiai

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

2025-07-11 16:05; UTC

Uždarbis

BASF Will Publish Half-Year Results on July 30

Akcijų palyginimas

Kainos pokytis

Assertio Holdings Inc Prognozė

Kainos tikslas

By TipRanks

305.8% į viršų

12 mėnesių prognozė

Vidutinis 2.8 USD  305.8%

Aukščiausias 3.5 USD

Žemiausias 1.5 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Assertio Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

4

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

0.618 / 0.649Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.